STOCK TITAN
  1. Home
  2. FSTX

F-Star Therapeutics Stock Price, News & Analysis

FSTX NASDAQ

Company Description

F-Star Therapeutics (NASDAQ: FSTX) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

FSTX stock has gained 145.9% over the past year.

This page provides a comprehensive overview of FSTX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
+145.94%
Performance 1 year
$0.0
Market Cap
22.0M
Shares outstanding

F-Star Therapeutics (FSTX) stock. Over the past 12 months, the stock has gained 145.9%.

Latest News

View All
—

invoX Pharma Completes Acquisition of F-star Therapeutics, Inc.

acquisition
+16.72%

F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma

acquisition
-26.24%

invoX Pharma and F-star Therapeutics issue Joint Statement

-2.34%

F-star Therapeutics Presents Clinical Data on FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, at ESMO-IO 2022 Congress

clinical trial
-3.37%

F-star Therapeutics Announces Publication of Phase 1 Dose-Escalation Trial of FS118 in Patients with Advanced Cancer and PD-L1 Resistance in Clinical Cancer Research

clinical trial
-0.76%

F-star Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights

earnings

F-Star Therapeutics has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 5 with negative movement. Key topics include acquisition, clinical trial, earnings. View all FSTX news →

SEC Filings

View All

No SEC filings available for FSTX.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

FSTX Company Profile & Sector Positioning

F-Star Therapeutics (FSTX) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.